Halpern Financial’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-29
Closed -$1.61K 271
2022
Q2
$1.61K Buy
+29
New +$1.61K ﹤0.01% 258